<DOC>
	<DOCNO>NCT02352129</DOCNO>
	<brief_summary>: Fibrosis , general , scar process , characterize fibroblast accumulation excess deposition extracellular matrix ( ECM ) proteins , lead distort organ architecture function . The contribution fibrogenesis impair cardiac function increasingly recognize . The fibrotic ECM cause increase stiffness induces pathological signal within cardiomyocytes result progressive cardiac failure . Also , excessive ECM impair mechano-electric couple cardiomyocytes increase risk arrhythmia . But today patient treatment prognosis base ejection fraction quantification , QRS duration , symptom . Hypothesis : increase level fibrosis quantify use T1 mapping technique , compare normal value , prognostic value patient dilate cardiomyopathy optimal treatment . Methods : 330 patient plan include follow 2 year</brief_summary>
	<brief_title>Prognostic Value Myocardial Fibrosis Quantified Using CMR Patient With Dilated Cardiomyopathy</brief_title>
	<detailed_description />
	<mesh_term>Cardiomyopathies</mesh_term>
	<mesh_term>Cardiomyopathy , Dilated</mesh_term>
	<criteria>patient dilate cardiomyopathy typical symptom cardiac insufficiency time diagnosis : oedema lower limb , dyspnoea , asthenia . reduction fraction ventricular ejection leave ( awkward ) 45 % measure echocardiography ( modify Simpson biplane ) associate volume télédiastolic volume superior normal echocardiography : &gt; 90ml / m2 ( modify Simpson biplane ) . Patients dysfunction VG secondary secondary overload pressure HTA severe valvulopathie coronary infringement ( achievement ) , prove history infarct gesture ( movement ) revascularisation ( bypass ( deck ) , stent ) coronary hurt least bi tronculaires significant severity explain ventriculaire failure .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>80 Years</maximum_age>
	<verification_date>July 2016</verification_date>
</DOC>